Rajni Agarwal-Hashmi

Clinical Trials

• Recruiting Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
• Not Recruiting The Adv Halt Trial
• Recruiting Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation
• Not Recruiting Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT
• Not Recruiting Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients
• Not Recruiting Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
• Not Recruiting A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
• Not Recruiting Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
• Not Recruiting Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
• Not Recruiting A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant
• Not Recruiting A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
• Not Recruiting Haploid Allogeneic Transplant Using the CliniMACS System
• Recruiting Phase I/II MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell